Document is current
Any future updates will be listed below
-
Authors
Cao, Can
Kang, Hye Jin
Singh, Isha
Chen, He
Zhang, Chengwei
Ye, Wenlei http://orcid.org/0000-0002-4694-1493
Hayes, Byron W.
Liu, Jing http://orcid.org/0000-0003-4740-243X
Gumpper, Ryan H.
Bender, Brian J.
Slocum, Samuel T.
Krumm, Brian E. http://orcid.org/0000-0001-6039-4767
Lansu, Katherine
McCorvy, John D. http://orcid.org/0000-0001-7555-9413
Kroeze, Wesley K.
English, Justin G.
DiBerto, Jeffrey F.
Olsen, Reid H. J.
Huang, Xi-Ping
Zhang, Shicheng http://orcid.org/0000-0002-5245-443X
Liu, Yongfeng http://orcid.org/0000-0002-8649-7892
Kim, Kuglae
Karpiak, Joel
Jan, Lily Y. http://orcid.org/0000-0003-3938-8498
Abraham, Soman N.
Jin, Jian http://orcid.org/0000-0002-2387-3862
Shoichet, Brian K. http://orcid.org/0000-0002-6098-7367
Fay, Jonathan F. http://orcid.org/0000-0003-1822-2384
Roth, Bryan L. http://orcid.org/0000-0002-0561-6520
- License Information
-
More Information
Article History
Received: 14 May 2021
Accepted: 8 October 2021
First Online: 17 November 2021
Competing interests
: A patent describing the MRGPRX2 antagonists has been filed by UCSF listing B.L.R., B.K.S., C.C., I.S. and H.J.K. as inventors.
